The discriminatory power of leptin mRNA was comparable to fasting blood glucose and HbA1c in distinguishing T2D patients and non-diabetic controls (AUROC = 0.95, 95% CI: 0.89–0.98) [65]. The gene discussed is LEP; the disease is type 2 diabetes mellitus.